Lincoln Pharma FY26 Net Profit ₹8,789 Lakhs, Recommends 18% Dividend

Lincoln Pharmaceuticals Limited announced its audited financial results for the quarter and year ended March 31, 2026. For the full fiscal year 2026, the company reported Revenue from Operations of ₹67,102.99 Lakhs and a Net Profit of ₹8,789.38 Lakhs. The Basic Earnings Per Share (EPS) for FY26 stood at ₹43.88. The Board of Directors also recommended a dividend of 18% (₹1.80 per equity share of face value ₹10/-) for the year ended March 31, 2026, subject to approval by shareholders at the upcoming Annual General Meeting. The audit reports for the financial results were issued with an unmodified opinion.